- Medicinal cannabis company Little Green Pharma (LGP) has entered a strategic partnership with private health insurer HIF
- Under the deal, HIF will issue a $105 rebate per script to eligible members for medicinal cannabis products
- The deal aims to improve access to and the affordability of medicinal cannabis
- Additionally, the partnership will support future research into medical cannabis, as HIF members will have priority participation in the research
- HIF is the first major Australian health fund to publicly support medicinal cannabis treatments
- Despite the positive news, Little Green Pharma is down 7.23 percent on the market this afternoon, trading for 38.5 cents per share